Jannel Lee-Allen, MD
Gastroenterology · East Lansing, MINPI 1700240819
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,831 of the $46,099 with a category attached, or 77.7%. Sanofi accounts for 60.5% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $41,049, more than ten times the $66 reported in 2019. Among gastroenterology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $128.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$28K
- Regeneron Healthcare Solutions, Inc.$11K
- AbbVie$1K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$886
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$583
- plus $3K from 24 others
What the payments were for
- Speaking & faculty fees$35,83178%
- Travel & lodging$2,2215%
- Food & beverage$7,94617%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 18 | $27,872 |
| Regeneron Healthcare Solutions, Inc. | 22 | $11,087 |
| AbbVie | 73 | $1,359 |
| Johnson & Johnson(2 entities) | 44 | $1,010 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $886 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 32 | $583 |
| Gilead | 25 | $565 |
| Pfizer | 17 | $383 |
| Lilly USA, LLC | 8 | $278 |
| Madrigal Pharmaceuticals | 10 | $212 |
| QOL Medical, LLC | 5 | $203 |
| Janssen Scientific Affairs, LLC | 3 | $194 |
| Ardelyx, Inc. | 8 | $150 |
| Celltrion USA Inc. | 12 | $144 |
| Intercept Pharmaceuticals, Inc. | 8 | $143 |
| Regeneron | 1 | $139 |
| Eisai Inc. | 1 | $125 |
| Bristol Myers Squibb | 7 | $116 |
| E.r. Squibb & Sons, L.L.C. | 1 | $115 |
| Ipsen Biopharmaceuticals, Inc | 6 | $103 |
| Braintree Laboratories, Inc. | 5 | $95 |
| Ironwood Pharmaceuticals, Inc | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 4 | $62 |
| Merck | 3 | $49 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Novo Nordisk | 1 | $23 |
| AstraZeneca | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,099 in reported general payments places this provider in the 90th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 24 | $18,794 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 45 | $7,163 |
| Omeprazole | 160 | $3,060 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 140 | $2,766 |
| Esomeprazole Magnesium | 43 | $1,895 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 84 | $1,570 |
| Pantoprazole Sodium | 47 | $880 |
| Carvedilol | 14 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,359 | $18,79424 claims |
| Braintree Laboratories, Inc.Sutab | $95 | $7,16345 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 497 gastroenterology providers in Michigan.
Other gastroenterology in East Lansing
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Partha NandiTroy$377K
- Bradford WhitmerSaint Clair Shores$206K
- Mohammed BarawiSt Clair Shores$193K
- Stuart GordonDetroit$178K
- Mohamad AlsibaeRoyal Oak$127K
- Allison SchulmanAnn Arbor$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.